Not necessarily, says Robert Koler, MD, in a recent blog post on WebMD. Over the past few weeks, the news buzz has been that aesthetic business is up, that plastic surgery is the new measuring stick for an economic recovery, and all will be right with the world again because of that. Not so fast, pardner.
Recently, a press release from one of the plastic surgery trade organizations reported that there was an increase in activity in the plastic surgery community. That was said to be the harbinger of better economic times to come.
Frankly, I am not so sure of that. The growth in cosmetic procedures is not in the surgical arena. It is in the non-surgical office treatment arena. So, as I see it, the increase in the “plastic surgery business” is not in plastic surgery but in the syringe and needle department.
Botox Cosmetic, Dysport, Restylane, Juvederm, Sculptra, and Radiesse, Artifill and medical-grade liquid silicone are all good and valuable treatments that patients are flocking to.
We cosmetic surgeons are glad to have these excellent products available to us, but the reality is, alone, they cannot do the job.
